Defects in Innate Immunity Render Breast Cancer Initiating Cells Permissive to Oncolytic Adenovirus

• Laura Ahtiainen ,

  * E-mail: laura.ahtiainen@helsinki.fi (LA); akseli.hemminki@helsinki.fi (AH)

  Affiliations Transplantation Laboratory, Cancer Gene Therapy Group, Molecular Cancer Biology Program, Haartman Institute and Finnish Institute of Molecular Medicine, University of Helsinki, Helsinki, Finland, HUSLAB, Helsinki University Central Hospital, Helsinki, Finland

  ⨯
• Cristina Mirantes,

  Affiliations Transplantation Laboratory, Cancer Gene Therapy Group, Molecular Cancer Biology Program, Haartman Institute and Finnish Institute of Molecular Medicine, University of Helsinki, Helsinki, Finland, HUSLAB, Helsinki University Central Hospital, Helsinki, Finland

  ⨯
• Tiina Jahkola,

  Affiliation Department of Plastic Surgery, Helsinki University Central Hospital, Helsinki, Finland

  ⨯
• Sophie Escutenaire,

  Affiliations Transplantation Laboratory, Cancer Gene Therapy Group, Molecular Cancer Biology Program, Haartman Institute and Finnish Institute of Molecular Medicine, University of Helsinki, Helsinki, Finland, HUSLAB, Helsinki University Central Hospital, Helsinki, Finland

  ⨯
• Iulia Diaconu,

  Affiliations Transplantation Laboratory, Cancer Gene Therapy Group, Molecular Cancer Biology Program, Haartman Institute and Finnish Institute of Molecular Medicine, University of Helsinki, Helsinki, Finland, HUSLAB, Helsinki University Central Hospital, Helsinki, Finland

  ⨯
• Pamela Österlund,

  Affiliation Viral Infections Unit, Department of Vaccination and Immune Protection, National Institute for Health and Welfare, Helsinki, Finland

  ⨯
• Anna Kanerva,

  Affiliations Transplantation Laboratory, Cancer Gene Therapy Group, Molecular Cancer Biology Program, Haartman Institute and Finnish Institute of Molecular Medicine, University of Helsinki, Helsinki, Finland, Department of Obstetrics and Gynaecology, Helsinki University Central Hospital, Helsinki, Finland

  ⨯
• Vincenzo Cerullo,

  Affiliations Transplantation Laboratory, Cancer Gene Therapy Group, Molecular Cancer Biology Program, Haartman Institute and Finnish Institute of Molecular Medicine, University of Helsinki, Helsinki, Finland, HUSLAB, Helsinki University Central Hospital, Helsinki, Finland

  ⨯
• Akseli Hemminki

  * E-mail: laura.ahtiainen@helsinki.fi (LA); akseli.hemminki@helsinki.fi (AH)

  Affiliations Transplantation Laboratory, Cancer Gene Therapy Group, Molecular Cancer Biology Program, Haartman Institute and Finnish Institute of Molecular Medicine, University of Helsinki, Helsinki, Finland, HUSLAB, Helsinki University Central Hospital, Helsinki, Finland

  ⨯